MedPath

Transcranial Magnetic Stimulation (TMS) for CRPS

Not Applicable
Completed
Conditions
Complex Regional Pain Syndrome (CRPS)
Interventions
Device: Transcranial Magnetic Stimulation (TMS)
Registration Number
NCT02067273
Lead Sponsor
Stanford University
Brief Summary

The purpose of this pilot study is to test the durability of response to Transcranial Magnetic Stimulation (TMS) for the symptoms of Complex Regional Pain Syndrome (CRPS). The investigators will test various methods of TMS for varying lengths of time in a pilot study to investigate what the clinical impact.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
20
Inclusion Criteria
  • Age 18 or older
  • Diagnosis of CRPS (complex regional pain syndrome)
  • Average pain level reported on Numerical Rating Scale meets entry criteria
  • Ability to perform the experimental task and procedures.
Read More
Exclusion Criteria
  • MRI contraindication (metal implants or devices, claustrophobia)
  • TMS Contraindication (eg metal implant or devices near the site of stimulation)
  • History of epilepsy
  • History of a psychological or psychiatric disorder that would interfere with study procedures, at the discretion of the researcher.
  • Neurologic illness that would interfere with brain integrity
  • Current medical condition or medication use that would interfere with study procedures or data integrity, at the discretion of the researcher.
  • Currently pregnant or planning to become pregnant.
  • On going legal action or disability claim.
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
TMS Intervention for 5 daysTranscranial Magnetic Stimulation (TMS)Application of Transcranial Magnetic Stimulation (TMS) for up to 5 days
TMS Intervention for 1 dayTranscranial Magnetic Stimulation (TMS)Application of Transcranial Magnetic Stimulation (TMS) for 1 day
Primary Outcome Measures
NameTimeMethod
Present Pain IntensityBaseline, post-treatment, one week follow-up

Present pain intensity was reported by participants using a visual analog scale (VAS) from scores ranging from 1-10; lower scores represent less pain, higher scores represent more severe pain.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Stanford University School of Medicine

🇺🇸

Palo Alto, California, United States

© Copyright 2025. All Rights Reserved by MedPath